Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Charter Communications
CHTR
5
Capital One Financial
COF
JP Stock MarketDetailed Quotes
4892 Cyfuse Biomedical KK
- 977
- +4+0.41%
20min DelayNot Open May 8 15:30 JST
8.11BMarket Cap-9.02P/E (Static)
979High962Low34.30KVolume970Open973Pre Close33.31MTurnover141252wk High0.76%Turnover Ratio8.30MShares43052wk Low-108.34EPS TTM4.39BFloat Cap2468Historical HighLossP/E (Static)4.49MShs Float430Historical Low-108.34EPS LYR1.75%Amplitude--Dividend TTM3.15P/B100Lot Size--Div YieldTTM
About Cyfuse Biomedical KK Company
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.
Company Profile
Symbol4892
Company NameCyfuse Biomedical KK
Founded2010-08-11
MarketTSE Growth
Fiscal Year Ends12-31
Address3-5-27, Mita West Wing-1st Floor. Sumitomo Fudosan Mita Twin Building
Zip Code108-6301
Phone03-6435-1885
Websitewww.cyfusebio.com
Company Executives
- Name
- Position
- Salary
- Masahiro Sanjo
- Chief Financial Officer and Head of Business Management Department
- --
- Tokunaga Tomohiko
- Director of Systems Development
- --
- Shizuka Akieda
- Representative Director
- --
- Yasuhiro Yoshioka
- Independent Director
- --
- Kunihiko Suzuki
- Independent Director
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting